Senseonics Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Senseonics stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares.
View analyst ratings for Senseonics or view top-rated stocks.

Wall Street analysts have given Senseonics a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Senseonics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Senseonics is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Senseonics.

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) posted its quarterly earnings data on Thursday, May, 13th. The company reported ($0.68) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.63.
View Senseonics' earnings history.

Senseonics issued an update on its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $12 million-15 million, compared to the consensus revenue estimate of $12.85 million.

5 brokerages have issued 12 month price objectives for Senseonics' stock. Their forecasts range from $1.00 to $3.00. On average, they expect Senseonics' stock price to reach $2.17 in the next twelve months. This suggests that the stock has a possible downside of 41.3%.
View analysts' price targets for Senseonics or view top-rated stocks among Wall Street analysts.

Some companies that are related to Senseonics include Mesa Laboratories (MLAB), Hurco Companies (HURC), ClearSign Technologies (CLIR), Crawford United (CRAWA), Hickok (HICKA), Sypris Solutions (SYPR), International Isotopes (INIS), Schmitt Industries (SMIT), Winland (WELX), Electro-Sensors (ELSE), Integral Vision (INVI), National Automation Services (NESV) and Universal Detection Technology (UNDT).
View all of SENS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), Advanced Micro Devices (AMD), Micron Technology (MU), Nabriva Therapeutics (NBRV), Sorrento Therapeutics (SRNE), Amarin (AMRN), Tandem Diabetes Care (TNDM), CytoDyn (CYDY), TransEnterix (TRXC) and TherapeuticsMD (TXMD).

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Masters Capital Management LLC (2.19%), BlackRock Inc. (1.32%), Gilder Gagnon Howe & Co. LLC (1.04%), Geode Capital Management LLC (0.55%), Renaissance Technologies LLC (0.42%) and Morgan Stanley (0.38%). Company insiders that own Senseonics stock include Douglas A Roeder, Douglas S Prince, Francine Kaufman, Mukul Jain, Stephen P Defalco and Timothy T Goodnow.
View institutional ownership trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including Gilder Gagnon Howe & Co. LLC, Daiwa Securities Group Inc., Rockefeller Capital Management L.P., Price T Rowe Associates Inc. MD, Perkins Capital Management Inc., Johnson & Johnson Innovation JJDC Inc., Dfpg Investments LLC, and Global Retirement Partners LLC. Company insiders that have sold Senseonics company stock in the last year include Douglas A Roeder, Douglas S Prince, Francine Kaufman, Mukul Jain, Stephen P Defalco, and Timothy T Goodnow.
View insider buying and selling activity for Senseonics or view top insider-selling stocks.

SENS stock was bought by a variety of institutional investors in the last quarter, including Masters Capital Management LLC, BlackRock Inc., Morgan Stanley, Geode Capital Management LLC, HRT Financial LP, Renaissance Technologies LLC, Northern Trust Corp, and Goldman Sachs Group Inc..
View insider buying and selling activity for Senseonics or or view top insider-buying stocks.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SENS stock can currently be purchased for approximately $3.69.

Senseonics has a market capitalization of $1.58 billion and generates $4.95 million in revenue each year. The company earns $-175,170,000.00 in net income (profit) each year or ($0.42) on an earnings per share basis.

Senseonics employs 82 workers across the globe.

The official website for Senseonics is www.senseonics.com.

Senseonics is headquartered at 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at (301) 515-7260.